Related Experiment Video
Updated: Aug 11, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
[Creatine kinase increases after coronary interventions]
M F Jiménez-Navarro1, E Curiel, J Alonso Briales
1Servicio de Cardiología. Hospital Clínico Universitario Virgen de la Victoria. Málaga.
Insights
Post-angioplasty creatine kinase elevations occurred in 7.7% of patients, often linked to side branch occlusion. Continuous monitoring of creatine kinase has low sensitivity for detecting complications, suggesting the need for more sensitive cardiac markers.
Area of Science:
- Cardiology
- Interventional Cardiology
Context:
- Percutaneous revascularization is a key treatment for symptomatic ischemic heart disease.
- The prognostic significance of postprocedural creatine kinase (CK) elevations after angioplasty remains controversial.
Purpose:
- To determine the incidence of post-angioplasty CK elevations.
- To identify factors associated with CK elevations.
- To evaluate the prognosis of patients with and without CK elevations.
Summary:
- A study of 309 patients undergoing angioplasty found CK elevations in 7.7% (24 patients).
- Procedure-related complications, primarily side branch occlusion, were observed in 50% of patients with CK elevations.
- No significant difference in major adverse coronary events was observed during follow-up between patients with and without CK elevations, despite a higher complication rate in the elevated CK group.
Impact:
- Continuous CK monitoring has low sensitivity for detecting post-angioplasty complications.
- The findings suggest that more sensitive cardiac biomarkers, such as troponin, may be necessary for accurate complication detection and patient risk stratification.
- This research contributes to understanding the clinical utility of CK monitoring in interventional cardiology.
Introduction And Objectives:
Percutaneous revascularization has led to an important change in the treatment of patients with symptomatic ischemic heart disease in recent years. There is controversy concerning the incidence and prognostic significance of postprocedural increases in creatine kinase. The aim of this study was to assess the incidence of these elevations and the related factors and to observe the prognosis of patients with and without creatin kinase elevations.
Methods:
We reviewed 447 patients in whom an angioplasty was done in our department from January 1997 to June 1998, excluding 138 patients with myocardial infarction in the previous four days or unsuccessful angioplasty. Creatine kinase was measured in all patients at 0, 4, 8 and 24 hours after angioplasty. We analyzed the incidence of elevated levels of creatine kinase following coronary surgery and the characteristics of the patients in comparison with a control group made up of patients who, at a similar time had undergone a similar angioplasty procedure including, a similar vessel and type of lesion, and equivalent left ventricular function but without elevated serum levels of creatine kinase. Major adverse coronary events were defined as: cardiac death, nonfatal myocardial infarction, new revascularization and unstable angina in which hospitalization was required.
Results:
Out of 309 patients studied, an elevation in creatine kinase was observed in 24 patients (7.7%). Complications related to the procedure were found in 50% of these elevations, most of which involved side branch occlusion. There were no differences with respect to the demographical or anatomical characteristics of the lesions in the groups studied. During the follow-up of 9.5 months, complications were observed in 37.5% of the group of patients with elevated creatine kinase levels and in 20% of the control group, but this difference did not achieve statistical significance.
Conclusions:
Creatine kinase elevations are produced in 7.7% of the patients after coronary angioplasty. Complications related to the procedure were observed in 50% of the cases, most being side branch occlusion and no complications were seen in the remaining patients. Continuous measurement of creatine kinase after angioplasty shows a low sensitivity for detecting complications during follow-up. New, more sensitive and specific cardiac markers, such as troponin, could define this group of patients.
Related Concept Videos
Muscle Recovery and Fatigue
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care

